Characteristic | Baseline Group (n = 353) | Small improve Group (n = 139) | No change Group (n = 65) |
---|---|---|---|
Age, years | 50.53 ± 13.48 | 51.64 ± 13.29 | 50.13 ± 14.78 |
Gender, male/female | 156/197 | 62/77 | 33/32 |
Disease duration, weeks | 261.28 ± 327.53 | 265.19 ± 327.92 | 370.07 ± 408.96 |
Occupation, active/retired | 94/259 | 41/98 | 15/49 |
Low back pain, n (%) | 319 (90.37%) | 125 (89.93%) | 60 (92.31%) |
Leg pain, n (%) | 322 (91.22%) | 126 (90.65%) | 57 (87.69%) |
Numbness of lower limb, n (%) | 203 (57.51%) | 75 (53.96%) | 39 (60.00%) |
Weakness of lower limb, n (%) | 64 (18.13%) | 21 (15.11%) | 19 (29.23%) |
Lesion location, n (%) | |||
 L1/L2 | 8 (2.27%) | 3 (2.16%) | 0 (00.00%) |
 L2/L3 | 18 (5.10%) | 7 (5.04%) | 2 (3.08%) |
 L3/L4 | 57 (16.15%) | 25 (17.99%) | 16 (24.62%) |
 L4/L5 | 236 (66.86%) | 97 (69.78%) | 49 (75.38%) |
 L5/S1 | 195 (55.24%) | 83 (59.71%) | 44 (67.69%) |
JOABPEQ | |||
 Q1 Low back pain | 31.10 ± 26.67 | 30.24 ± 26.16 | 38.55 ± 30.21 |
 Q2 Lumbar function | 44.59 ± 27.52 | 43.30 ± 27.07 | 53.65 ± 28.52 |
 Q3 Walking ability | 56.62 ± 30.46 | 54.92 ± 30.49 | 65.40 ± 29.98 |
 Q4 Social life function | 35.88 ± 21.40 | 36.15 ± 21.03 | 41.01 ± 21.89 |
 Q5 Mental health | 42.56 ± 18.88 | 41.52 ± 18.89 | 43.22 ± 17.30 |
NPRS | 5.68 ± 2.19 | 6.07 ± 1.75 | 4.37 ± 2.06 |
ODI | 49.57 ± 22.47 | 51.44 ± 21.84 | 45.39 ± 24.01 |
RMDQ | 13.31 ± 6.45 | 13.58 ± 6.45 | 10.89 ± 7.07 |
SF-36 PCS | 40.56 ± 20.47 | 40.08 ± 20.10 | 45.94 ± 21.52 |
SF-36 MCS | 50.84 ± 21.69 | 50.07 ± 21.59 | 51.90 ± 19.87 |